Autorizzazione alla conduzione dello Studio “Observational study to assess the efficacy and safety of bendamustine plus rituximab in patients affected by chronic lumphocytic leukemia” . Codice: LLC1315
|
Delibera n° 226
|
Delibere e determine/delibere-2016
11/10/2016